Pharmaceuticals News and Research

RSS
Boehringer Ingelheim, Zealand Pharma partner to develop Type-2 diabetes and obesity agonists

Boehringer Ingelheim, Zealand Pharma partner to develop Type-2 diabetes and obesity agonists

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE

ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE

Brain research funds crisis: Report

Brain research funds crisis: Report

Spectrum board authorizes $25 million stock repurchase program

Spectrum board authorizes $25 million stock repurchase program

Cardinal Health renews pharmaceutical distribution agreement with Prime Therapeutics

Cardinal Health renews pharmaceutical distribution agreement with Prime Therapeutics

NIH awards $20 million research grant to University of Kentucky

NIH awards $20 million research grant to University of Kentucky

Saint-Gobain introduces new C-Flex ULTRA TPE pump tubing for biopharmaceutical applications

Saint-Gobain introduces new C-Flex ULTRA TPE pump tubing for biopharmaceutical applications

Pharma IQ launches Global HTA and CER Forum

Pharma IQ launches Global HTA and CER Forum

Russian CRO market expects to report yearly growth of 9.5% between 2009 and 2017

Russian CRO market expects to report yearly growth of 9.5% between 2009 and 2017

OncoSec Medical third quarter net loss increases to $491,000

OncoSec Medical third quarter net loss increases to $491,000

QIAGEN to acquire Ipsogen

QIAGEN to acquire Ipsogen

APP announces $38 million expansion of New York manufacturing facility

APP announces $38 million expansion of New York manufacturing facility

Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID

Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

immatics initiates IMA901 Phase III trial in renal cell carcinoma

immatics initiates IMA901 Phase III trial in renal cell carcinoma

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.